Compugen (CGEN) Revenue Growth (1y) (2010 - 2026)
Compugen (CGEN) Revenue Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 35.46% |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 7.82% |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 19.04% |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 64.30% |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Compugen | 215.59 Mn | 123.84 Mn | 352,000.00 | -4.73% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.73% |
| Dec 31, 2025 | 4,477.29% |
| Sep 30, 2025 | -88.96% |
| Jun 30, 2025 | -81.24% |
| Mar 31, 2025 | -10.75% |
| Dec 31, 2024 | -95.60% |
| Dec 31, 2023 | 346.12% |
| Dec 31, 2016 | -99.36% |
| Sep 30, 2016 | -69.43% |
| Jun 30, 2016 | 122.42% |
| Mar 31, 2016 | -81.87% |
| Dec 31, 2015 | 26.88% |
| Sep 30, 2015 | -86.67% |
| Jun 30, 2015 | -88.65% |
| Mar 31, 2015 | -75.95% |
| Dec 31, 2014 | 269.13% |
| Sep 30, 2014 | 8.05% |
| Jun 30, 2014 | 8,827.27% |
| Mar 31, 2014 | 1,216.67% |
| Dec 31, 2013 | 1,224.63% |